Search research articles
Contact Us
Filters
Showing results (71-80 of 115) with videos related to
Page
of 12
Sort By:
Human Molecular Genetics
|
January 23, 2010
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma
Alessandra Bisio, Sabina Nasti, Jennifer J Jordan, et al.
EMBO Reports
|
July 7, 2022
Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster
Giuseppe Aiello, Cosimo Sabino, Davide Pernici, et al.
Journal of Hepatology
|
May 28, 2014
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma
Mirko Tarocchi, Simone Polvani, Anna Julie Peired, et al.
Journal of Personalized Medicine
|
October 27, 2022
Next Generation Sequencing Analysis of MODY-X Patients: A Case Report Series
Giulio Maltoni, Roberto Franceschi, Valeria Di Natale, et al.
European Journal of Pharmacology
|
November 21, 2017
TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy
Sanja Aveic, Diana Corallo, Elena Porcù, et al.
Cell Reports
|
April 3, 2020
Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30
Dario Rizzotto, Sara Zaccara, Annalisa Rossi, et al.
Nucleic Acids Research
|
August 5, 2015
RiboAbacus: a model trained on polyribosome images predicts ribosome density and translational efficiency from mammalian transcriptomes
Fabio Lauria, Toma Tebaldi, Lorenzo Lunelli, et al.
BMC Cancer
|
November 7, 2015
EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition
Chiara Zucal, Vito G D'Agostino, Antonio Casini, et al.
Journal of Chemical Information and Modeling
|
February 28, 2024
Pliability in the m<sup>6</sup>A-Binding Region Extends Druggability of YTH Domains
Giulia Cazzanelli, Andrea Dalle Vedove, Giovanni Spagnolli, et al.
Leukemia
|
June 3, 2018
SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells
Yang Liang, Toma Tebaldi, Kai Rejeski, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 115) with videos related to
Sort By:
Page
of 12
Human Molecular Genetics
|
January 23, 2010
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma
Alessandra Bisio, Sabina Nasti, Jennifer J Jordan, et al.
EMBO Reports
|
July 7, 2022
Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster
Giuseppe Aiello, Cosimo Sabino, Davide Pernici, et al.
Journal of Hepatology
|
May 28, 2014
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma
Mirko Tarocchi, Simone Polvani, Anna Julie Peired, et al.
Journal of Personalized Medicine
|
October 27, 2022
Next Generation Sequencing Analysis of MODY-X Patients: A Case Report Series
Giulio Maltoni, Roberto Franceschi, Valeria Di Natale, et al.
European Journal of Pharmacology
|
November 21, 2017
TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy
Sanja Aveic, Diana Corallo, Elena Porcù, et al.
Cell Reports
|
April 3, 2020
Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30
Dario Rizzotto, Sara Zaccara, Annalisa Rossi, et al.
Nucleic Acids Research
|
August 5, 2015
RiboAbacus: a model trained on polyribosome images predicts ribosome density and translational efficiency from mammalian transcriptomes
Fabio Lauria, Toma Tebaldi, Lorenzo Lunelli, et al.
BMC Cancer
|
November 7, 2015
EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition
Chiara Zucal, Vito G D'Agostino, Antonio Casini, et al.
Journal of Chemical Information and Modeling
|
February 28, 2024
Pliability in the m<sup>6</sup>A-Binding Region Extends Druggability of YTH Domains
Giulia Cazzanelli, Andrea Dalle Vedove, Giovanni Spagnolli, et al.
Leukemia
|
June 3, 2018
SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells
Yang Liang, Toma Tebaldi, Kai Rejeski, et al.
Page
of 12